MBBS (Singapore) – ABIM Int. Med (USA) – ABIM Med Onc(USA) – FAMS (Medical Oncology)
Dr. Kevin Tay is a Senior Consultant Medical Oncologist with the OncoCare Cancer Center and also a Visiting Consultant at the National Cancer Center Singapore. Dr. Tay received his medical degree from the National University of Singapore, School of Medicine and did his post-graduate training in Internal Medicine at the University of Hawaii and his Medical Oncology fellowship at the National Cancer Institute (NCI), National Institute of Health (NIH) in USA. Dr. Tay was also appointed Chief Resident and Chief Fellow during both his residency and fellowship program respectively. He currently holds American Board certifications for the practice of Internal Medicine and Medical Oncology.
During his time at the National Cancer Institute (NCI) and the National Institute of Health (NIH) in USA, Dr Tay trained under several renowned oncologists, including Dr Sandy Swain, a world expert on breast cancer and the previous President of the American Society of Clinical Oncology, and Dr Giuseppe Giaccone, the previous Chair of the EORTC’s Lung Cancer Cooperative Group and also the Associate Director for Clinical Research at the Lombardi Comprehensive Cancer Center, Georgetown University. Dr Tay also spent two years doing research at the NIH with an internationally renowned translational research group, under the mentorship of Dr Wyndham Wilson, Dr Louis Staudt and Dr Elaine Jaffe.
Upon returning to Singapore in early 2010, Dr. Tay joined the Department of Medical Oncology at National Cancer Center. He continued to be active in translational research and is part of the core group at the National Cancer Center Singapore. He was recognized as one of top cancer doctor doing research, that was awarded the prestigious center grant by the National Medical Research Council of Singapore. In addition, Dr Tay is actively collaborating with other leading Asian researchers from Korea, Taiwan and Hong Kong as well with his former colleagues at the National Institute of Health in USA in genomic oncology research. Dr Tay has also published widely in numerous journals, including the Nature Genetics, the Journal of Clinical Oncology, The Lancet Hematology, American Journal of Medicine, Leukemia & Lymphoma and Seminars in Hematology. He is also a member of the SingHealth Institutional Review Board, designated to approve, monitor and review the research activities within SingHealth since 2010.
Dr Tay’s subspecialty interest is in women related cancers such as breast cancers and gynaecological cancers, soft tissue and bone sarcomas and also hematological malignancies such as lymphoma, multiple myeloma and leukemia.